Xiao, F. ., Xiao, W. ., Li, X., Li, R. . and Zhao, K. . (2024) “Cost-effectiveness analysis of Trastuzumab Deruxtecan as second-line treatment for HER2- positive advanced breast cancer”, Health Decision, 2(S1). doi: 10.54844/hd.2024.0009.